Merck 2010 Annual Report Download - page 15

fields, including innovative lighting materials based on LEDs and OLEDs,
energy storage materials for the automotive sector, and products for the
photovoltaics industry that will be used in the next generation of solar
cells.
With Merck Millipore, we want to position ourselves as the leading
supplier to the life science industry, for instance in the biopharmaceutical
market, which is highly profitable and is currently growing at 12% a year.
Cooperating with customers on research and development programs is
a common feature of processes in modern biotech production where we
transform our expertise in chemicals and pharmaceuticals into innovation.
Once the production process has been approved for a drug, this leads to
benefits for our customers, who seek joint, long-term success with a supplier
they can trust.
At Merck Serono, we are concentrating on specialist therapeutic areas
with high unmet medical needs. Our research activities are focused on three
areas: Oncology, Neurodegenerative Diseases and Rheumatology. In parallel
with the development of specific therapies, it is our aim to develop patient
stratification methods: We want to focus even more closely on how our
drugs act in certain groups of patients and how therapeutic efficacy can be
predicted for individual patients.
We aspire to be a company where an enjoyment of work and innovative
strength meet. Merck stands out because it offers an inspiring and moti-
vating work environment in which all employees have the opportunity to
make extraordinary achievements while developing themselves further.
And this is why our more than 40,000 employees apply themselves ener-
getically to the benefit of customers and the company. We owe you, our
shareholders and customers, our thanks for your support and trust. My
Executive Board colleagues and I will continue to do everything we can to
merit this trust.
11Corporate governance Consolidated Financial Statements More information
Company Management Report